18 results
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
mL/minute/1.73 m2 ... disease Common Side ... Effects and Toxicities ... : • GI side effects ... Pharmacology #Summary #DM2
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
in CKD Common Side ... Effects and Toxicities ... Pharmacology #Summary #DM2
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
mL/minute/1.73 m2 ... of use) Common Side ... Effects and Toxicities ... Pharmacology #Summary #DM2
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
pancreatitis Common Side ... Effects and Toxicities ... : • Gl side effects ... Pharmacology #Summary #DM2
Anemia Diagnostic Algorithm

Mean corpuscular (cell) volume (MCV): Average RBC size. Under 80 = microcytic. Between 80-95
Anemia Diagnostic Algorithm ... ): Average RBC size ... Algorithm by Dr. ... podcast #Anemia #Algorithm ... #Diagnosis #Workup
Amyloidosis - Workup and Diagnostic Algorithm
 • Serum Immunofixation and Serum Free Light Chains
 • Biopsy
Amyloidosis - Workup ... and Diagnostic Algorithm ... Biopsy Surrogate Site ... #Amyloidosis #Workup ... #Diagnosis #Algorithm
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
They work primarily ... Common side effects ... upset (since it works ... and injection site ... Dosing #Diabetes #DM2
Causes of Hypokalemia - Differential Diagnosis Algorithm
Once pseudohypokalemia is ruled out, causes of hypokalemia can be
Differential Diagnosis Algorithm ... with the drain wide ... Differential #Diagnosis #Algorithm ... #Causes #workup
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
failure Common Side ... Effects and Toxicities ... Pharmacology #Summary #DM2
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
These work by inhibiting ... drugs include side ... Side effects include ... #Medications #DM2